USANA Health Sciences Inc (USNA) - Total Liabilities
Based on the latest financial reports, USANA Health Sciences Inc (USNA) has total liabilities worth $144.18 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore USANA Health Sciences Inc (USNA) net asset momentum to track the company's year-over-year net asset growth rate.
USANA Health Sciences Inc - Total Liabilities Trend (1995–2025)
This chart illustrates how USANA Health Sciences Inc's total liabilities have evolved over time, based on quarterly financial data. See USNA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
USANA Health Sciences Inc Competitors by Total Liabilities
The table below lists competitors of USANA Health Sciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shin Hai Gas Corp
TW:9926
|
Taiwan | NT$4.57 Billion |
|
BAIC Motor Corp Ltd
F:2B5
|
Germany | €89.42 Billion |
|
Famous Brands Ltd
JSE:FBR
|
South Africa | ZAC2.09 Billion |
|
Aluflexpack AG
SW:AFP
|
Switzerland | CHF290.87 Million |
|
Jasmine International Public Company Limited
BK:JAS
|
Thailand | ฿7.08 Billion |
|
Viking Tech
TWO:3624
|
Taiwan | NT$606.74 Million |
|
Shenzhen Sine Electric Co. Ltd. A
SHG:688395
|
China | CN¥164.89 Million |
|
Advanced Ceramic X
TWO:3152
|
Taiwan | NT$437.44 Million |
Liability Composition Analysis (1995–2025)
This chart breaks down USANA Health Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see USANA Health Sciences Inc market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how USANA Health Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for USANA Health Sciences Inc (1995–2025)
The table below shows the annual total liabilities of USANA Health Sciences Inc from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $156.64 Million | -3.22% |
| 2024-12-31 | $161.86 Million | +19.41% |
| 2023-12-31 | $135.56 Million | -16.36% |
| 2022-12-31 | $162.08 Million | -11.25% |
| 2021-12-31 | $182.62 Million | -8.34% |
| 2020-12-31 | $199.24 Million | +20.59% |
| 2019-12-31 | $165.22 Million | +1.17% |
| 2018-12-31 | $163.32 Million | +4.65% |
| 2017-12-31 | $156.06 Million | +7.36% |
| 2016-12-31 | $145.35 Million | +2.09% |
| 2015-12-31 | $142.38 Million | +18.24% |
| 2014-12-31 | $120.42 Million | +11.55% |
| 2013-12-31 | $107.95 Million | +31.99% |
| 2012-12-31 | $81.78 Million | +15.86% |
| 2011-12-31 | $70.59 Million | +20.38% |
| 2010-12-31 | $58.64 Million | +19.51% |
| 2009-12-31 | $49.06 Million | -45.93% |
| 2008-12-31 | $90.74 Million | +28.72% |
| 2007-12-31 | $70.49 Million | +77.09% |
| 2006-12-31 | $39.80 Million | +42.31% |
| 2005-12-31 | $27.97 Million | +17.42% |
| 2004-12-31 | $23.82 Million | +14.77% |
| 2003-12-31 | $20.76 Million | -1.26% |
| 2002-12-31 | $21.02 Million | +0.93% |
| 2001-12-31 | $20.83 Million | -7.92% |
| 2000-12-31 | $22.62 Million | -5.36% |
| 1999-12-31 | $23.90 Million | +154.26% |
| 1998-12-31 | $9.40 Million | +32.39% |
| 1997-12-31 | $7.10 Million | -18.39% |
| 1996-12-31 | $8.70 Million | +141.67% |
| 1995-12-31 | $3.60 Million | -- |
About USANA Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Ess… Read more